One portion of the parallel studies followed over 16,000 women for an average of 5.2 years, half of whom took placebo, while the other half took a combination of the progestin medroxyprogesterone acetate (Provera) and conjugated equine estrogen (Premarin).
The study reported statistically significant increases in rates of breast cancer, coronary heart disease, strokes and pulmonary emboli.